A key knowledge gap lies in fully characterizing the kinases and phosphatases that regulate Bad phosphorylation in various cancer types, and how this regulation might be exploited therapeutically to restore Bad’s pro-apoptotic function. The gene discussed is BAD; the disease is cancer.